Novel PD-1 blockade bioassay to assess therapeutic antibodies in PD-1 and PD-L1 immunotherapy programs

被引：9
|
作者：
Cheng, Zhi-Jie Jey [1 ]
Karassina, Natasha [1 ]
Grailer, Jamison [1 ]
Hartnett, Jim [1 ]
Fan, Frank [1 ]
Cong, Mei [1 ]
机构：
[1] Promega Corp, Madison, WI USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-5440
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5440
引用
收藏
页数：2
相关论文
共 50 条
  • [11] PD-1/PD-L1 Are Novel Therapeutic Targets for Mastocytosis
    Geeze, Mary
    Hatch, Ellen
    Martin, Cheyenne
    Perkins, Sherrie L.
    Hartmann, Karin
    Valent, Peter
    Gotlib, Jason
    Lidke, Diane
    George, Tracy I.
    LABORATORY INVESTIGATION, 2016, 96 : 346A - 346A
  • [12] PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy
    Bocanegra, Ana
    Blanco, Ester
    Fernandez-Hinojal, Gonzalo
    Arasanz, Hugo
    Chocarro, Luisa
    Zuazo, Miren
    Morente, Pilar
    Vera, Ruth
    Escors, David
    Kochan, Grazyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 17
  • [13] Toxicities Associated With PD-1/PD-L1 Blockade
    Wang, Daniel Y.
    Johnson, Douglas B.
    Davis, Elizabeth J.
    CANCER JOURNAL, 2018, 24 (01): : 36 - 40
  • [14] Mechanisms of Resistance to PD-1 and PD-L1 Blockade
    Nowicki, Theodore S.
    Hu-Lieskovan, Siwen
    Ribas, Antoni
    CANCER JOURNAL, 2018, 24 (01): : 47 - 53
  • [15] PD-1 and PD-L1 blockade in gastrointestinal malignancies
    Lote, Hazel
    Cafferkey, Catherine
    Chau, Ian
    CANCER TREATMENT REVIEWS, 2015, 41 (10) : 893 - 903
  • [16] PD-1/PD-L1 and immunotherapy for pancreatic cancer
    Feng, Mengyu
    Xiong, Guangbing
    Cao, Zhe
    Yang, Gang
    Zheng, Suli
    Song, Xujun
    You, Lei
    Zheng, Lianfang
    Zhang, Taiping
    Zhao, Yupei
    CANCER LETTERS, 2017, 407 : 57 - 65
  • [17] PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer
    Yaghoubi, Neda
    Soltani, Arash
    Ghazvini, Kiarash
    Hassanian, Seyed Mahdi
    Hashemy, Seyed Isaac
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 312 - 318
  • [18] Development of cancer immunotherapy based on PD-1/PD-L1 pathway blockade
    Zhang, Min
    Liu, Kehai
    Wang, Mingfu
    RSC ADVANCES, 2019, 9 (58) : 33903 - 33911
  • [19] Current status of PD-1/PD-L1 blockade immunotherapy in breast cancer
    Noguchi, Emi
    Shien, Tadahiko
    Iwata, Hiroji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (03) : 321 - 332
  • [20] Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
    Hsu, Joy
    Hodgins, Jonathan J.
    Marathe, Malvika
    Nicolai, Chris J.
    Bourgeois-Daigneault, Marie-Claude
    Trevino, Troy N.
    Azimi, Camillia S.
    Scheer, Amit K.
    Randolph, Haley E.
    Thompson, Thornton W.
    Zhang, Lily
    Iannello, Alexandre
    Mathur, Nikhita
    Jardine, Karen E.
    Kirn, Georgia A.
    Bell, John C.
    McBurney, Michael W.
    Raulet, David H.
    Ardolino, Michele
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (10): : 4654 - 4668
12345